1. Anti‐envelope antibody responses in individuals at high risk of hepatitis C virus who resist infection. Issue 11 (13th July 2016) Authors: Swann, R. E.; Mandalou, P.; Robinson, M. W.; Ow, M. M.; Foung, S. K. H.; McLauchlan, J.; Patel, A. H.; Cramp, M. E. Journal: Journal of viral hepatitis Issue: Volume 23:Issue 11(2016) Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of generic oral directly acting agents in patients with hepatitis C virus infection. Issue 7 (22nd March 2018) Authors: Gupta, S.; Rout, G.; Patel, A. H.; Mahanta, M.; Kalra, N.; Sahu, P.; Sethia, R.; Agarwal, A.; Ranjan, G.; Kedia, S.; Acharya, S. K.; Nayak, B.; Shalimar, Journal: Journal of viral hepatitis Issue: Volume 25:Issue 7(2018) Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Elevated interferon‐stimulated gene transcription in peripheral blood mononuclear cells occurs in patients infected with genotype 1 but not genotype 3 hepatitis C virus. Issue 4 (9th September 2014) Authors: Robinson, M. W.; Swann, R.; Sigruener, A.; Barclay, S. T.; Mills, P. R.; McLauchlan, J.; Patel, A. H. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 4(2015) Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗